| dc.contributor.author | Musayeva N.B., Islamova Z.S. | |
| dc.date.accessioned | 2023-05-07T18:08:30Z | |
| dc.date.available | 2023-05-07T18:08:30Z | |
| dc.date.issued | 2023-04 | |
| dc.identifier.uri | http://repository.tma.uz/xmlui/handle/1/7644 | |
| dc.description.abstract | At the same time, according to the results of the study, the antithrombin potential of the blood increases with the progression of the disease, which can be considered as a consequence of the anti-inflammatory effect of prolonged immunosuppressive therapy and a decrease in the exudative component in the evolution of the disease. The increase in antithrombin potential, according to our data, does not include the activation of antithrombin III, which requires a study to clarify the involvement of other natural anticoagulants in the formation of increased antithrombin activity in the blood of RA patients | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | KLINIK LABORATOR DIAGNOSTIKADA INNOVATSION TEXNOLOGIYALARDAN FOYDALANISH, MUAMMOLAR VA YECHIMLAR | en_US |
| dc.relation.ispartofseries | №2; | |
| dc.subject | Hemostatic disorders,rheumatoid arthritis, Wilcoxon-Mann-Whitney,Spearman's rank | en_US |
| dc.title | Hemostasiological changes in rheumatoid arthritis | en_US |
| dc.type | Thesis | en_US |